was read the article
array:24 [ "pii" => "S234128792030209X" "issn" => "23412879" "doi" => "10.1016/j.anpede.2020.02.011" "estado" => "S300" "fechaPublicacion" => "2021-01-01" "aid" => "2810" "copyrightAnyo" => "2020" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "An Pediatr (Barc). 2021;94:48-50" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1695403320300928" "issn" => "16954033" "doi" => "10.1016/j.anpedi.2020.02.011" "estado" => "S300" "fechaPublicacion" => "2021-01-01" "aid" => "2810" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "An Pediatr (Barc). 2021;94:48-50" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">CARTA CIENTÍFICA</span>" "titulo" => "Sarcoidosis sistémica: cuando la esplenomegalia no es lo que parece" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "48" "paginaFinal" => "50" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Systemic sarcoidosis; when splenomegaly is not what it seems" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figura 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 544 "Ancho" => 1300 "Tamanyo" => 88835 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">a) Hepatoesplenomegalia tardía. No se detectó afectación pulmonar. b) Adenopatías hipermetabólicas (SUVmáx 3,89). Esplenomegalia hipermetabólica (SUVmáx 3,15).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Álvaro Cobreros-Pérez, Rocío Galindo-Zavala, Begoña Carazo-Gallego, Laura Martín-Pedraz, Esmeralda Núñez-Cuadros" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Álvaro" "apellidos" => "Cobreros-Pérez" ] 1 => array:2 [ "nombre" => "Rocío" "apellidos" => "Galindo-Zavala" ] 2 => array:2 [ "nombre" => "Begoña" "apellidos" => "Carazo-Gallego" ] 3 => array:2 [ "nombre" => "Laura" "apellidos" => "Martín-Pedraz" ] 4 => array:2 [ "nombre" => "Esmeralda" "apellidos" => "Núñez-Cuadros" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S234128792030209X" "doi" => "10.1016/j.anpede.2020.02.011" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S234128792030209X?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403320300928?idApp=UINPBA00005H" "url" => "/16954033/0000009400000001/v1_202101060630/S1695403320300928/v1_202101060630/es/main.assets" ] ] "itemSiguiente" => array:20 [ "pii" => "S2341287920302088" "issn" => "23412879" "doi" => "10.1016/j.anpede.2020.02.010" "estado" => "S300" "fechaPublicacion" => "2021-01-01" "aid" => "2805" "copyright" => "Asociación Española de Pediatría" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "An Pediatr (Barc). 2021;94:50-1" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Lysosomal acid lipase deficiency: A rarely recognised cause of dyslipidaemia and liver dysfunction" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "50" "paginaFinal" => "51" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Deficiencia de lipasa ácida lisosomal: una causa poco reconocida de dislipemia y disfunción hepática" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Marta Marín Andrés, Ignacio Ros Arnal, Jorge Javier Cebolla Sanz, Raquel Pérez Delgado, María Concepción García Jiménez" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Marta" "apellidos" => "Marín Andrés" ] 1 => array:2 [ "nombre" => "Ignacio" "apellidos" => "Ros Arnal" ] 2 => array:2 [ "nombre" => "Jorge Javier" "apellidos" => "Cebolla Sanz" ] 3 => array:2 [ "nombre" => "Raquel" "apellidos" => "Pérez Delgado" ] 4 => array:2 [ "nombre" => "María Concepción" "apellidos" => "García Jiménez" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1695403320300813" "doi" => "10.1016/j.anpedi.2020.02.006" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403320300813?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287920302088?idApp=UINPBA00005H" "url" => "/23412879/0000009400000001/v1_202101160808/S2341287920302088/v1_202101160808/en/main.assets" ] "itemAnterior" => array:20 [ "pii" => "S2341287920302118" "issn" => "23412879" "doi" => "10.1016/j.anpede.2020.02.012" "estado" => "S300" "fechaPublicacion" => "2021-01-01" "aid" => "2812" "copyright" => "Asociación Española de Pediatría" "documento" => "simple-article" "crossmark" => 1 "licencia" => "http://creativecommons.org/licenses/by-nc-nd/4.0/" "subdocumento" => "crp" "cita" => "An Pediatr (Barc). 2021;94:46-8" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific letter</span>" "titulo" => "Observational and cross-sectional study on the use of homoeopathy in a paediatric emergency care service" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "46" "paginaFinal" => "48" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Estudio observacional transversal sobre el uso de homeopatía en un servicio de urgencias pediátricas" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 669 "Ancho" => 2500 "Tamanyo" => 113102 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">a. Number of homoeopathic products used in the year previous to participation in the survey. b. Frequency distribution of the source that recommended use of homoeopathic products in the total sample of responses.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Alicia Arévalo-Cenzual, Lucía Garriga Ferrer-Bergua, Marta Cabrero-Hernández, David Andina-Martínez, Alberto García-Salido" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Alicia" "apellidos" => "Arévalo-Cenzual" ] 1 => array:2 [ "nombre" => "Lucía" "apellidos" => "Garriga Ferrer-Bergua" ] 2 => array:2 [ "nombre" => "Marta" "apellidos" => "Cabrero-Hernández" ] 3 => array:2 [ "nombre" => "David" "apellidos" => "Andina-Martínez" ] 4 => array:2 [ "nombre" => "Alberto" "apellidos" => "García-Salido" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1695403320300941" "doi" => "10.1016/j.anpedi.2020.02.013" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403320300941?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287920302118?idApp=UINPBA00005H" "url" => "/23412879/0000009400000001/v1_202101160808/S2341287920302118/v1_202101160808/en/main.assets" ] "en" => array:15 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Systemic sarcoidosis; when splenomegaly is not what it seems" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "48" "paginaFinal" => "50" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Álvaro Cobreros-Pérez, Rocío Galindo-Zavala, Begoña Carazo-Gallego, Laura Martín-Pedraz, Esmeralda Núñez-Cuadros" "autores" => array:5 [ 0 => array:4 [ "nombre" => "Álvaro" "apellidos" => "Cobreros-Pérez" "email" => array:1 [ 0 => "alvaro_cobre@msn.com" ] "referencia" => array:2 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">a</span>" "identificador" => "aff0005" ] 1 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:3 [ "nombre" => "Rocío" "apellidos" => "Galindo-Zavala" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 2 => array:3 [ "nombre" => "Begoña" "apellidos" => "Carazo-Gallego" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">c</span>" "identificador" => "aff0015" ] ] ] 3 => array:3 [ "nombre" => "Laura" "apellidos" => "Martín-Pedraz" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] 4 => array:3 [ "nombre" => "Esmeralda" "apellidos" => "Núñez-Cuadros" "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">b</span>" "identificador" => "aff0010" ] ] ] ] "afiliaciones" => array:3 [ 0 => array:3 [ "entidad" => "Unidad de Gestión Clínica de Pediatría, Hospital Materno Infantil, Hospital Regional Universitario de Málaga, Málaga, Spain" "etiqueta" => "a" "identificador" => "aff0005" ] 1 => array:3 [ "entidad" => "Unidad de Reumatología Pediátrica, Unidad de Gestión Clínica de Pediatría, Hospital Materno Infantil, Hospital Regional Universitario de Málaga, Málaga, Spain" "etiqueta" => "b" "identificador" => "aff0010" ] 2 => array:3 [ "entidad" => "Unidad de Infectología Pediátrica, Unidad de Gestión Clínica de Pediatría, Hospital Materno Infantil, Hospital Regional Universitario de Málaga, Málaga, Spain" "etiqueta" => "c" "identificador" => "aff0015" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Sarcoidosis sistémica: cuando la esplenomegalia no es lo que parece" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 544 "Ancho" => 1300 "Tamanyo" => 88835 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(a) Late-onset hepatosplenomegaly. No signs of pulmonary involvement. (b) Hypermetabolic lymphadenopathy (maximum standardized uptake value [SUVmax], 3.89). Hypermetabolic splenomegaly (SUVmax, 3.15).</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">Sarcoidosis is a rare multisystemic disease characterized by the development of noncaseating granulomas in different tissues.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,2</span></a> There are 2 forms of juvenile sarcoidosis: early-onset sarcoidosis or Blau syndrome, and late-onset sarcoidosis, which is of unknown aetiology and has a heterogeneous clinical presentation, although pulmonary manifestations are most frequent.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,4</span></a> Splenic involvement is rare, and only a few cases of it have been published in the literature.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">We present 2 cases of juvenile sarcoidosis with onset with massive splenomegaly.</p><p id="par0015" class="elsevierStylePara elsevierViewall">Case 1: boy aged 11 years with no relevant history that presented with fever of 12 days’ duration, mild lymph node enlargement in the submandibular, axillary and inguinal regions, and hepatosplenomegaly detectable on palpation through the iliac fossa. The salient findings of blood tests were leukopenia (1570/mm<span class="elsevierStyleSup">3</span>), neutropenia (610/mm<span class="elsevierStyleSup">3</span>) and thrombocytopenia (77<span class="elsevierStyleHsp" style=""></span>000/mm<span class="elsevierStyleSup">3</span>), confirmed by examination of a peripheral blood smear, a creatinine level of 0.93<span class="elsevierStyleHsp" style=""></span>mg/dL and hypertransaminasaemia (aspartame aminotransferase, 73<span class="elsevierStyleHsp" style=""></span>U/L; alanine aminotransferase, 85<span class="elsevierStyleHsp" style=""></span>U/L). There was no elevation of C-reactive protein or the erythrocyte sedimentation rate. The findings of the chest radiograph were unremarkable, and the abdominal ultrasound scan confirmed the presence of hepatosplenomegaly.</p><p id="par0020" class="elsevierStylePara elsevierViewall">Serological tests, cultures and viral polymerase chain reaction tests for viral detection (including cytomegalovirus and Epstein–Barr virus [EBV]), as were the Mantoux test and QuantiFERON assay. Immunoglobulin levels were normal. The patient had an elevated level of angiotensin converting enzyme (ACE, 248.9<span class="elsevierStyleHsp" style=""></span>U/L; normal range, 8–55<span class="elsevierStyleHsp" style=""></span>U/L) and hypercalcaemia (10.86<span class="elsevierStyleHsp" style=""></span>mg/dL).</p><p id="par0025" class="elsevierStylePara elsevierViewall">The patient underwent a magnetic resonance scan of the thorax and abdomen and a positron emission tomography (PET) scan (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>).</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0030" class="elsevierStylePara elsevierViewall">The bone marrow biopsy revealed an absence of cancerous cells, and the lymph node biopsy the presence of Schaumann bodies.</p><p id="par0035" class="elsevierStylePara elsevierViewall">These findings, having ruled out an infectious or cancerous aetiology, led to diagnosis of sarcoidosis.</p><p id="par0040" class="elsevierStylePara elsevierViewall">During the diagnostic process, the fever and blood test abnormalities resolved, and the hepatosplenomegaly improved, so the episode was considered to be self-limited.</p><p id="par0045" class="elsevierStylePara elsevierViewall">At 18 months, the patient experienced a recurrence of leukopenia, hypertransaminasaemia and elevation of ACE. The ultrasound scan revealed nephrocalcinosis. This led to initiation of treatment with oral corticosteroids at a dose of 0.5<span class="elsevierStyleHsp" style=""></span>mg/kg/day, with a positive response, although the patient also required methotrexate delivered subcutaneously at a dose of 15<span class="elsevierStyleHsp" style=""></span>mg/m<span class="elsevierStyleSup">2</span>/week that was eventually switched to adalimumab due to the presence of hypertransaminasaemia. During the follow-up, the patient developed a new episode triggered by infection that resolved with corticosteroids.</p><p id="par0050" class="elsevierStylePara elsevierViewall">Case 2: boy aged 4 years with persisting hepatosplenomegaly 8 months after diagnosis of primary infection by EBV with serological confirmation. The abdominal ultrasound scan revealed massive splenomegaly and mesenteric lymphadenopathy, and the EBV load in blood remained detectable at 100<span class="elsevierStyleHsp" style=""></span>000<span class="elsevierStyleHsp" style=""></span>copies/mL, while all other infection screening tests were negative.</p><p id="par0055" class="elsevierStylePara elsevierViewall">A month later, the patient developed fever and the number and size of involved lymph nodes in the abdominal region increased. The blood EBV load exhibited a decreasing trend. The patient underwent screening for X-linked autoimmune lymphoproliferative syndrome (ALPS) and bone marrow and lymph node biopsies, with detection of necrotising epithelioid granulomas.</p><p id="par0060" class="elsevierStylePara elsevierViewall">Three months later, when the EBV load in blood was undetectable, the patient experienced a recurrence of fever accompanied by anemia and hypertransaminasaemia. The computed tomography scan of the thorax and abdomen revealed mediastinal and abdominal lymphadenopathy and 24 nodules in the lungs (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>a), which led to performance of additional biopsies (lymph node and spleen) that revealed sarcoid-like nonspecific granulomatous lymphadenitis. The Mantoux test and QuantiFERON assay were both negative. Examination of a bronchoalveolar lavage sample revealed a CD4/CD8 ratio of 3.92 (normal range, 0.9–1.9). The serum level of ACE was 239<span class="elsevierStyleHsp" style=""></span>U/L.</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><p id="par0065" class="elsevierStylePara elsevierViewall">Following diagnosis of sarcoidosis, the patient started treatment with systemic corticosteroids (1<span class="elsevierStyleHsp" style=""></span>mg/kg/day) and later on with methotrexate, which achieved a reduction in the number of pulmonary nodules and in the size of the spleen.</p><p id="par0070" class="elsevierStylePara elsevierViewall">Although in the initial evaluation the level of immunoglobulins had been within the normal range, during the follow-up the patient developed hypogammaglobulinemia. After intensification of immunosuppression with adalimumab and administration of several doses of intravenous immunoglobulin, the levels recovered and remained normal over time without immunoglobulin replacement therapy, which ruled out common variable immune deficiency. The patient became asymptomatic and the number of nodules had decreased significantly at 10 years of follow-up (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>b).</p><p id="par0075" class="elsevierStylePara elsevierViewall">In conclusion, sarcoidosis is a disease that is rare and exhibits a heterogeneous clinical presentation in the pediatric age group.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,2</span></a> Splenomegaly, described in fewer than 10% of affected adults, may be present in up to 50% of pediatric cases, and be severe in some, as was the case in our sample. This entails an extensive differential diagnosis<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> including neoplasias and ALPS, especially in the presence of cytopenia, and infection (especially tuberculosis) and immune deficiencies in case of pulmonary involvement. Common variable immune deficiency has a similar presentation,<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> as it may have onset with splenomegaly and one of its most frequent complications is granulomatous-lymphocytic interstitial lung disease, so it is essential that immunoglobulin levels are measured before initiating immunosuppressive therapy. On the other hand, X-linked lymphoproliferative disease should be considered in male patients if the trigger is EBV infection, as was the case of the second patient presented here.</p><p id="par0080" class="elsevierStylePara elsevierViewall">Nephrocalcinosis is a complication described in up to 10% of cases,<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> highlighting the need of monitoring to guide treatment planning and prevent sequelae.</p><p id="par0085" class="elsevierStylePara elsevierViewall">As for treatment, there is no standardized approach to the management of systemic sarcoidosis in the pediatric population. Steroid therapy is the first-line treatment, as is the case in adult patients.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,6</span></a> In refractory or steroid-dependent cases, there is the option of adding an immunosuppressive agent such as methotrexate or anti-TNF-α.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a></p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "NotaPie" => array:2 [ 0 => array:2 [ "etiqueta" => "⋆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Cobreros-Pérez Á, Galindo-Zavala R, Carazo-Gallego B, Martín-Pedraz L, Núñez-Cuadros E. Sarcoidosis sistémica: cuando la esplenomegalia no es lo que parece. An Pediatr (Barc). 2021;94:48–50.</p>" ] 1 => array:2 [ "etiqueta" => "⋆⋆" "nota" => "<p class="elsevierStyleNotepara" id="npar0010">Previous presentations: this study was presented at the 46th Annual Meeting of the Sociedad de Pediatría de Andalucía Oriental, March 2019, Jaen, Spain; and the 67th Congress of the Asociación Española de Pediatría, June 2019, Burgos, Spain.</p>" ] ] "multimedia" => array:2 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 544 "Ancho" => 1300 "Tamanyo" => 88835 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">(a) Late-onset hepatosplenomegaly. No signs of pulmonary involvement. (b) Hypermetabolic lymphadenopathy (maximum standardized uptake value [SUVmax], 3.89). Hypermetabolic splenomegaly (SUVmax, 3.15).</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 930 "Ancho" => 2167 "Tamanyo" => 124764 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">(a) Before treatment with anti-TNF-α: multiple well-delimited parenchymal nodules with a subpleural, peripheral location and a maximum diameter of 11<span class="elsevierStyleHsp" style=""></span>mm. No evidence of pulmonary fibrosis. Findings compatible with stage 2 pulmonary sarcoidosis. (b) After treatment with anti-TNF-α: significant decrease in the number and size of pulmonary nodules.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0015" "bibliografiaReferencia" => array:6 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Paediatric sarcoidosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "N. Nathan" 1 => "C. Sileo" 2 => "A. Calender" 3 => "Y. Pacheco" 4 => "D. Valeyre" 5 => "A. Clement" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.prrv.2018.05.003" "Revista" => array:6 [ "tituloSerie" => "Paediatr Respir Rev" "fecha" => "2019" "volumen" => "29" "paginaInicial" => "53" "paginaFinal" => "59" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/30917882" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Pediatric sarcoidosis presenting as huge splenomegaly" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "L.M. Sherief" 1 => "O.T. Amer" 2 => "W.A. Mokhtar" 3 => "N.M. Kamal" 4 => "H.M. Ibrahim" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/ped.13219" "Revista" => array:6 [ "tituloSerie" => "Pediatr Int" "fecha" => "2017" "volumen" => "59" "paginaInicial" => "366" "paginaFinal" => "367" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28317306" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Lung sarcoidosis in children: update on disease expression and management" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "N. Nathan" 1 => "P. Marcelo" 2 => "V. Houdouin" 3 => "R. Epaud" 4 => "J. de Blic" 5 => "D. Valeyre" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/thoraxjnl-2015-206825" "Revista" => array:6 [ "tituloSerie" => "Thorax" "fecha" => "2015" "volumen" => "70" "paginaInicial" => "537" "paginaFinal" => "542" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/25855608" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Childhood sarcoidosis in Denmark 1979–1994: incidence, clinical features and laboratory results at presentation in 48 children" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "A.L. Hoffmann" 1 => "N. Milman" 2 => "K.E. Byg" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:6 [ "tituloSerie" => "Acta Paediatr" "fecha" => "2004" "volumen" => "93" "paginaInicial" => "30" "paginaFinal" => "36" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/14989436" "web" => "Medline" ] ] ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "British Lung Foundation/United Kingdom Primary Immunodeficiency Network Consensus Statement on the Definition Diagnosis, and Management of Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "J.R. Hurst" 1 => "N. Verma" 2 => "D. Lowe" 3 => "H.E. Baxendale" 4 => "S. Jolles" 5 => "P. Kelleher" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaip.2017.01.021" "Revista" => array:6 [ "tituloSerie" => "J Allergy Clin Immunol Pract" "fecha" => "2017" "volumen" => "5" "paginaInicial" => "938" "paginaFinal" => "945" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/28351785" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Approaches to the treatment of some of the troublesome manifestations of sarcoidosis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A. Eklund" 1 => "R.M. du Bois" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/joim.12198" "Revista" => array:6 [ "tituloSerie" => "J Intern Med" "fecha" => "2014" "volumen" => "275" "paginaInicial" => "335" "paginaFinal" => "349" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/24433397" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23412879/0000009400000001/v1_202101160808/S234128792030209X/v1_202101160808/en/main.assets" "Apartado" => array:4 [ "identificador" => "38181" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Scientific letters" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23412879/0000009400000001/v1_202101160808/S234128792030209X/v1_202101160808/en/main.pdf?idApp=UINPBA00005H&text.app=https://analesdepediatria.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S234128792030209X?idApp=UINPBA00005H" ]
Year/Month | Html | Total | |
---|---|---|---|
2024 November | 11 | 14 | 25 |
2024 October | 93 | 30 | 123 |
2024 September | 70 | 45 | 115 |
2024 August | 74 | 66 | 140 |
2024 July | 80 | 33 | 113 |
2024 June | 74 | 37 | 111 |
2024 May | 66 | 32 | 98 |
2024 April | 70 | 24 | 94 |
2024 March | 61 | 28 | 89 |
2024 February | 84 | 28 | 112 |
2024 January | 82 | 22 | 104 |
2023 December | 81 | 22 | 103 |
2023 November | 110 | 27 | 137 |
2023 October | 89 | 31 | 120 |
2023 September | 65 | 29 | 94 |
2023 August | 52 | 11 | 63 |
2023 July | 78 | 28 | 106 |
2023 June | 51 | 21 | 72 |
2023 May | 75 | 23 | 98 |
2023 April | 52 | 12 | 64 |
2023 March | 71 | 22 | 93 |
2023 February | 79 | 23 | 102 |
2023 January | 48 | 20 | 68 |
2022 December | 65 | 13 | 78 |
2022 November | 67 | 32 | 99 |
2022 October | 69 | 47 | 116 |
2022 September | 58 | 25 | 83 |
2022 August | 75 | 46 | 121 |
2022 July | 61 | 30 | 91 |
2022 June | 58 | 24 | 82 |
2022 May | 75 | 45 | 120 |
2022 April | 56 | 29 | 85 |
2022 March | 93 | 49 | 142 |
2022 February | 95 | 24 | 119 |
2022 January | 132 | 38 | 170 |
2021 December | 96 | 46 | 142 |
2021 November | 106 | 29 | 135 |
2021 October | 133 | 76 | 209 |
2021 September | 62 | 32 | 94 |
2021 August | 48 | 33 | 81 |
2021 July | 44 | 18 | 62 |
2021 June | 65 | 37 | 102 |
2021 May | 78 | 46 | 124 |
2021 April | 191 | 96 | 287 |
2021 March | 77 | 47 | 124 |
2021 February | 61 | 21 | 82 |
2021 January | 71 | 53 | 124 |
2020 December | 59 | 26 | 85 |